In a research note released Tuesday, Goldman Sachs (nyse: GS - news - people ) biotech analyst May-Kin Ho wrote that positive results in this study could double the number of patients eligible for the therapy to 700, 000 people.

FORBES: Kick Starting Amgen

Investors may not be quite so gung-ho in future.

ECONOMIST: Credit derivatives: Rites of passage | The

Macau Chief Executive-designate Edmund Ho (no relation) has said other companies may be allowed to operate casinos when the franchise expires.

CNN: ASIANOW - Asiaweek | Daily Briefing: Holiday Hiatus? Hardly